GADD 45α siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemGADD 45α siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-35440
Gene Namegrowth arrest and DNA-damage-inducible, alpha
Quantity10 µM
Specieshuman
NCBI Full Gene Namegrowth arrest and DNA damage inducible alpha
NCBI Gene AliasesDDIT1, GADD45
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) GADD45A suppression contributes to cardiac remodeling by promoting inflammation, fibrosis and hypertrophyCell Mol Life SciApril 30, 2025Adel Rostami, Xavier Palomer, Javier Pizarro-Delgado, Lucía Peña, Mònica Zamora, Marta Montori-Grau, Emma Barroso, Brenda Valenzuela-Alcaraz, Fàtima Crispi, Jesús M. Salvador, et al.(siRNA)-mediated GADD45A gene silencing was carried out by transfecting AC16 cells with human GADD45A siRNA (sc-35440; Santa Cruz Biotechnology, Inc., Dallas TX, USA), using scrambled siRNA as a transfection control. Fluorescein-labeled

(2) Epigenetic therapy combination of UNC0638 and CI-994 suppresses breast cancer via epigenetic remodeling of BIRC5 and GADD45ABiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieJanuary 1, 2022Lin HY, Wu HJ, Chen SY, Hou MF, Lin CS, Chu PY.

(3) EGR1/GADD45α Activation by ROS of Non-Thermal Plasma Mediates Cell Death in Thyroid CarcinomaCancersJanuary 19, 2021Jung SN, Oh C, Chang JW, Liu L, Lim MA, Jin YL, Piao Y, Kim HJ, Won HR, Lee SE, et al.

(4) Chelidonine Induces Apoptosis via GADD45a-p53 Regulation in Human Pancreatic Cancer CellsIntegrative cancer therapiesJanuary 1, 2021Jang HJ, Yang JH, Hong E, Jo E, Lee S, Lee S, Choi JS, Yoo HS, Kang H.purchased from Santa Cruz (USA). After seeding, cells were transfected with sc-29435 (p53 siRNA) and sc-35440 (GADD45a siRNA) using Hillymax (Japan) according to manufacturer’s instructions. After 48 hours later

(5) Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human OsteosarcomaInternational journal of molecular sciencesJune 24, 2020Godel M, Morena D, Ananthanarayanan P, Buondonno I, Ferrero G, Hattinger CM, Di Nicolantonio F, Serra M, Taulli R, Cordero F, et al.transfected with 0.5 µg of Control non-targeting siRNA plasmid (sc-37007); GADD 45α siRNA plasmid (sc-35440); c-Myc siRNA plasmid (sc-29226) (all from Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). In over-expression

(6) Gadd45a sensitizes medulloblastoma cells to irradiation and suppresses MMP-9-mediated EMTNeuro-oncologyOctober 1, 2011Asuthkar S, Nalla AK, Gondi CS, Dinh DH, Gujrati M, Mohanam S, Rao JS.

(7) GADD45a is a novel candidate gene in inflammatory lung injury via influences on Akt signalingFASEB journal : official publication of the Federation of American Societies for Experimental BiologyMay 1, 2009Meyer NJ, Huang Y, Singleton PA, Sammani S, Moitra J, Evenoski CL, Husain AN, Mitra S, Moreno-Vinasco L, Jacobson JR, et al.

Be the First to Write a Review!

GADD 45α siRNA (h)

GADD 45α siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (7)

Reviews

GADD 45α siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map